<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03508986</url>
  </required_header>
  <id_info>
    <org_study_id>CFPDR</org_study_id>
    <nct_id>NCT03508986</nct_id>
  </id_info>
  <brief_title>Chinese FPD Registry</brief_title>
  <official_title>The Chinese Familial Parkinson's Disease Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiangya Hospital of Central South University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the Chinese Familial Parkinson's disease Registry (CFPDR) is to develop a
      database of patients with familial Parkinson's disease (PD) in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parkinson's disease (PD) is the second most common disorder among degenerative neurological
      disease. Familial PD (FPD) has its unique clinical feature and genetic basis. We aim to
      establish a database of FPD,and characterize the clinical feature, genetic basis,
      environmental factors and their interactions FPD in China.

      Method:

        1. Clinical feature will be measured by scales and neurological tests.Standard scales
           includes: Unified Parkinson's Disease Rating Scale(UPDRS), Hoehn-Yahr stages, NMSS,
           MMSE, PDSS(Parkinson disease sleep scales),Rapid Eye Movement Sleep Behaviour Disorder
           Questionnaire(RBDQ-HK),ESS(Epworth Sleepiness Scale),Rome III functional constipation
           scale，SCOPA-AUT (the Scale for Outcomes in PD for Autonomic Symptoms)，PFS(Parkinson
           Fatigue Scale)，CH-RLSq，Hyposmia rating scale(HRS)HAMILT depression scale，the 39-item
           Parkinson's Disease Questionnaire(PDQ-39)，Freezing of gait scale(FOG)，dyskinesia related
           scales, Wearing-off scale(WO)

        2. Peripheral blood from patients and other members in family will be collected for
           familial PD genetic testing.

        3. The environmental factors are exploded by questionnaires including smoking,drinking,
           pesticide and heavy metals.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">February 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Database of Familial Parkinson's disease</measure>
    <time_frame>10 years</time_frame>
    <description>To collect 1500 patients with familial Parkinson's disease and establish the database of Familial Parkinson's disease (FPD) in mainland China.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk Factors</measure>
    <time_frame>10 years</time_frame>
    <description>To characterize clinical feature and environmental factors among Chinese familial parkinson's disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic Basis</measure>
    <time_frame>10 years</time_frame>
    <description>To characterize the genetic basis of Chinese FPD and detect clinically relevant genetic variants in these cases</description>
  </primary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Parkinson Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Extraction of DNA from peripheral blood of patients and other family members in familial PD
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in hospitals or community
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Parkinson's disease, and either family history of Parkinson's
             disease (first or second degree family member affected by Parkinson's disease) AND/OR
             Clinical diagnosis of Parkinson's disease and their parents are close relatives(First
             or second degree family member of an Index Case, affected or unaffected by Parkinson's
             disease).

        Exclusion Criteria:

          -  Lack of capacity to consent to participate in the project
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Jifeng Guo, Ph.D.</last_name>
    <phone>+8613974936815</phone>
    <email>guojifeng2003@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beisha Tang, Ph.D.</last_name>
    <phone>+8613974856709</phone>
    <email>bstang7398@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jifeng Guo, Ph.D.</last_name>
      <phone>+8613974936815</phone>
      <email>guojifeng2003@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Qiying Sun, Ph.D.</last_name>
      <phone>+8615874907260</phone>
      <email>sunqiying2015@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Yan W, Tang B, Zhou X, Lei L, Li K, Sun Q, Xu Q, Yan X, Guo J, Liu Z. TMEM230 mutation analysis in Parkinson's disease in a Chinese population. Neurobiol Aging. 2017 Jan;49:219.e1-219.e3. doi: 10.1016/j.neurobiolaging.2016.10.007. Epub 2016 Oct 11.</citation>
    <PMID>27814995</PMID>
  </reference>
  <reference>
    <citation>Yang Y, Tang BS, Weng L, Li N, Shen L, Wang J, Zuo CT, Yan XX, Xia K, Guo JF. Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism. PLoS One. 2015 Aug 21;10(8):e0136245. doi: 10.1371/journal.pone.0136245. eCollection 2015.</citation>
    <PMID>26295349</PMID>
  </reference>
  <reference>
    <citation>Li K, Tang BS, Liu ZH, Kang JF, Zhang Y, Shen L, Li N, Yan XX, Xia K, Guo JF. LRRK2 A419V variant is a risk factor for Parkinson's disease in Asian population. Neurobiol Aging. 2015 Oct;36(10):2908.e11-5. doi: 10.1016/j.neurobiolaging.2015.07.012. Epub 2015 Jul 11.</citation>
    <PMID>26234753</PMID>
  </reference>
  <results_reference>
    <citation>Liu Z, Guo J, Li K, Qin L, Kang J, Shu L, Zhang Y, Wei Y, Yang N, Luo Y, Sun Q, Xu Q, Yan X, Tang B. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease. Neurobiol Aging. 2015 Nov;36(11):3117.e7-3117.e8. doi: 10.1016/j.neurobiolaging.2015.08.010. Epub 2015 Aug 15.</citation>
    <PMID>26343503</PMID>
  </results_reference>
  <results_reference>
    <citation>Guo JF, Li K, Yu RL, Sun QY, Wang L, Yao LY, Hu YC, Lv ZY, Luo LZ, Shen L, Jiang H, Yan XX, Pan Q, Xia K, Tang BS. Polygenic determinants of Parkinson's disease in a Chinese population. Neurobiol Aging. 2015 Apr;36(4):1765.e1-1765.e6. doi: 10.1016/j.neurobiolaging.2014.12.030. Epub 2015 Jan 6.</citation>
    <PMID>25623333</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2018</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

